GREGORY D PERRY Insider Trading
Get free email notifications about insider trading for GREGORY D PERRY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY D PERRY. GREGORY D PERRY is a See Remarks in QLT INC/BC ($QLTI) and a Sr. VP & CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and a VP, Finance & CEO in TRANSKARYOTIC THERAPIES INC ($TKTX) and a VP, Finance and CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and a Director in Ocata Therapeutics, Inc. ($ACTC) and a in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Chief Financial Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and a See Remarks in Aegerion Pharmaceuticals, Inc. ($AEGR) and a in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Kala Pharmaceuticals, Inc. ($KALA) and a Chief Financial and Business in Eleven Biotherapeutics, Inc. ($EBIO) and a Chief Financial Officer in Finch Therapeutics Group, Inc. ($FNCH).
Address: 700 MAIN STREET CAMBRIDGE 02139 MA
Companies in which GREGORY D PERRY is an Insider
Aegerion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY:
Holdings: 0 shares
Latest Transaction: Nov 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Finch Therapeutics Group, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GREGORY D PERRY: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Mar 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kala Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY:
Holdings: 40,000 shares
Latest Transaction: Jun 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY: See Remarks
Holdings: 2,393 shares
Latest Transaction: May 11 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY: Director
Holdings: 0 shares
Latest Transaction: Feb 11 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY: Chief Financial and Business
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2015
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TRANSKARYOTIC THERAPIES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GREGORY D PERRY: Sr. VP & CFO, VP, Finance and CFO, VP, Finance & CEO
Holdings: 0 shares
Latest Transaction: Mar 28 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GREGORY D PERRY
Sentiment: All, AEGR, FNCH, KALA, NVLN, ACTC, SESN, TKTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Grant | A | 0.00 | 20,000 | 0 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Mar 18 2021 | FNCH | Finch Therapeutics ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 17.00 | 55,386 | 941,562 | 55,386 | |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 07 2019 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Option Exercise | A | 5.35 | 21,000 | 112,350 | 21,000 | |
| Mar 02 2018 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Option Exercise | A | 14.05 | 25,920 | 364,176 | 25,920 | |
| May 11 2017 | QLTI | NOVELION THERAPEUT ... | PERRY GREGORY D | See Remarks | Option Exercise | M | 0.00 | 2,393 | 0 | 4,786 | |
| May 11 2017 | QLTI | NOVELION THERAPEUT ... | PERRY GREGORY D | See Remarks | Payment of Exercise | F | 9.42 | 710 | 6,688 | 1,683 | 2.4 K to 1.7 K (-29.67 %) |